Natixis Penumbra Inc Transaction History

Natixis

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$238.08 - $288.0 $9.38 Million - $11.3 Million	-39,400 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$250.72 - $291.24 $9.88 Million - $11.5 Million	39,400 New	39,400 $10.5 Million
Q2 2021 Aug 13, 2021	SELL	$235.0 - $310.7 $1.56 Million - $2.06 Million	-6,638 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$175.6 - $291.43 $366,301 - $607,922	-2,086 Reduced 23.91%	6,638 $1.8 Million
Q4 2020 Feb 12, 2021	BUY	$174.98 - $272.83 $1.53 Million - $2.38 Million	8,724 New	8,724 $1.53 Million
Q4 2019 Feb 14, 2020	SELL	$134.81 - $177.8 $464,824 - $613,054	-3,448 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$131.82 - $183.4 $454,515 - $632,363	3,448 New	3,448 $464,000
Q4 2017 Feb 14, 2018	SELL	$91.55 - $115.85 $335,713 - $424,821	-3,667 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$79.65 - $90.3 $292,076 - $331,130	3,667	3,667 $331,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.